TYROGENEX
Tyrogenex, Inc., a biotechnology company, engages in research and development of multi-kinase angiogenesis inhibitor for the treatment of solid tumors. The company has developed a novel, patented cancer therapeutic, X-82, a dual VEGFR/PDGFR inhibitor. The company was formerly known as Xcovery, Inc. The company was incorporated in 2006 and is based in West Palm Beach, Florida. The company operates as a subsidiary of Xcovery LLC.
TYROGENEX
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2006-01-01
Address:
West Palm Beach, Florida, United States
Country:
United States
Website Url:
http://www.tyrogenex.com
Total Employee:
1+
Status:
Active
Contact:
+1 (855) 978-7025
Total Funding:
21.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Employees Featured
Founder
Investors List
Brace Pharma
Brace Pharma investment in Series D - Tyrogenex
